检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:魏芳晶[1] 阴淑莹[1] 张晓云[1] 王翠艳[1] 徐敏[1]
机构地区:[1]内蒙古医学院附属医院保健中心,内蒙古呼和浩特010050
出 处:《内蒙古医学院学报》2009年第4期353-356,共4页Acta Academiae Medicinae Neimongol
基 金:内蒙古自治区自然科学基金(200711020938)
摘 要:目的:探讨未接受介入治疗的不同类型心绞痛病人血清基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶组织抑制因子-1(TIMP-1)水平的变化与近期预后的关系。方法:46例不稳定型心绞痛病人为UAP组,36例稳定型心绞痛病人为SAP组,30名体检健康者为对照组。比较各组血清MMP-9和TIMP-1水平变化;随访3mo主要心血管事件。结果:UAP组入院第1d MMP-9水平高于SAP组(P>0.05),前者持续在第3d(272.23±20.09 vs 165.57±22.34)ng/mL、第7d继续升高(337.35±53.12 vs 125.22±27.25)ng/mL,后者则持续下降(P<0.05);TIMP-1表现同样的变化趋势。3mo随访期间发生心脏事件33例,无心脏事件49例。有心脏事件入院第1、3、7d血清MMP-9水平高于无心脏事件(P<0.05)。结论:UAP病人MMP-9、TIMP-1血清水平动态升高,与近期心血管事件有关。MMP-9、TIMP-1可作为不同类型心绞痛病人危险分层的指标之一。Objective:To study the serum level of matrix metalloproteinase-9(MMP-9),tissue inhibitors of matrix metalloproteinase-1(TIMP-1)and its short-term prognosticvalue for patients with angina pectoris(AP).Methods:46 cases of patients with unstable angina pectoris(UAP) and 36 cases of patients with stable angina pectoris(SAP).While 30 cases of healthy individuals were selected as control group.The serum levels of MMP-9 and TIMP-1 were compared.Results:Serum levels of MMP-9 were significantly higher at 3rd day(272.23±20.09 vs 165.57±22.34)ng/mL、and 7th day(337.35±53.12 vs 125.22±27.25)ng/mL in UAP group than those in the SAP group(P〈0.05).In the follow-up 3 months,cardiac events group(n=33) had higher serum level of MMP-9 than those of no cardiac events group(n=49)(P〈0.05).Conclusion:The serum level of MMP-9 plays important role in occurrence of cardiac events and short-term prognostic.It could be one index of cardiac events.
关 键 词:心绞痛 基质金属蛋白酶-9 基质金属蛋白酶组织抑制因子-1
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117